Cipla trades in green on the BSE

Cipla is currently trading at Rs. 394.40, up by 3.45 points or 0.88% from its previous closing of Rs. 390.95 on the BSE. The scrip opened at Rs. 392.00 and has touched a high and low of Rs. 396.25 and Rs. 390.30 respectively. So far 42853 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 450.00 on 16-Sep-2013 and a 52 week low of Rs. 364.05 on 03-Jun-2013. Last one week high and low of the scrip stood at Rs. 406.00 and Rs. 389.30 respectively. The current market cap of the company is Rs. 31695.32 crore. The promoters holding in the company stood at 36.80%, while Institutions and Non-Institutions held 34.75% and 27.35% respectively. Foreign Institutional Investors (FIIs) have reduced their stake in Cipla to 23.32% during Q4 FY14 from 23.79% as on December 31, 2013. On the other hand, domestic institutional investors’ (DIIs) shareholding went up to 11.43% at the end of March 2014 quarter from 10.60% as on December 31, 2013. Under DIIs, Insurance companies held maximum stake of 6.73%, followed by mutual funds / UTI (4.43% stake) and financial institutions / banks (0.27% stake). Meanwhile, promoter and promoter group shareholding was unchanged at 36.80% at the end of March 2014 quarter. Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.